People: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

25 Nov 2015
Change (% chg)

$-0.28 (-0.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Lanchbury, Jerry 

Dr. Jerry S. Lanchbury Ph.D. is Chief Scientific Officer of Myriad Genetics, Inc. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named Chief Scientific Officer in February 2010. Dr. Lanchbury came to us from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.

Basic Compensation

Total Annual Compensation, USD 733,643
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,855,300
Fiscal Year Total, USD 2,588,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 105,786 2,156,310.00
Name Fiscal Year Total

John Henderson


Mark Capone


Walter Gilbert


Richard Marsh


Jayne Hart


Gary King

As Of  29 Jun 2014
Search Stocks